Gilead Sciences, Inc (GILD) Gilead Sciences Completes Acquisition of Arcellx Ahead of Potential Commercial Launch of Anito-cel

Gilead Sciences, Inc (NASDAQ: GILD) FY 2026 Other Release

Newsdesk: